CAMPAIGN PRIORITY: Precision Medicine

Doylestown Health is proud of our long history of innovative, compassionate care coupled with a uniquely human approach that treats each and every patient as an individual. Precision medicine—also known as personalized medicine—encompasses our forward-thinking care model, emphasizing the importance of treatment personalized down to the molecular level, and has the potential to improve clinical workflow efficiency, diagnostic quality, and ultimately create personalized diagnosis and treatment plans for patients.¹

According to the National Institutes of Health (NIH), precision medicine is “an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person.” The goal of precision medicine is to design a treatment strategy based on each patient’s unique genetic profile, in order to yield more effective treatments and better outcomes. Instead of the traditional “one size fits all” approach, in which all patients with the same diagnosis receive the same treatment, Doylestown Health’s precision medicine applies targeted therapies based on unique genetic profiles resulting in better outcomes.

Your investment will support the acquisition of state-of-the-art testing technology that can determine the sequence of patients’ DNA or RNA, and study genetic variations associated with diseases. In turn, this testing will reduce the time from biopsy to diagnosis by more than 50 percent, allowing patients to begin treatment—and healing—faster.

¹ Cui, M., Zhang, D.Y. Artificial intelligence and computational pathology. Lab Invest